Results 171 to 180 of about 11,674 (220)
Complications of Therapeutic Plasma Exchange in Pediatric Neuroimmune Disorders. [PDF]
Children (Basel)Eichinger K, Breu M, Renken M, Siegert S, Hilz E, Glatter S, Csaicsich D, Boehm M, Lechner C, Kornek B, Seidl R. +10 moreeuropepmc +1 more sourceDominant rhabdomyolysis linked to a recurrent ATP2A2 variant reducing SERCA2 function in muscle. [PDF]
BrainMalaichamy S, Idoux R, Polavarapu K, Šikić K, Holla E, Thompson R, Spendiff S, Schänzer A, Küsters B, Freeman E, Hentschel A, O'Neil D, Carmona-Martinez R, Dobelmann V, Tucht C, Schouten M, Ruck T, Schara-Schmidt U, Kamsteeg EJ, Ramadža DP, Jakovčević A, Žigman T, Čavka M, Karcagi V, Herczegfalvi A, Laurie S, Matalonga L, Beltran S, Horvath R, Voermans N, Roos A, Barić I, Lochmüller H. +32 moreeuropepmc +1 more sourceClinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy: A Nonrandomized Controlled Trial.
JAMA PediatrSchwartz O, Vill K, Pfaffenlehner M, Behrens M, Weiß C, Johannsen J, Friese J, Hahn A, Ziegler A, Illsinger S, Smitka M, von Moers A, Kölbel H, Schreiber G, Kaiser N, Wilichowski E, Flotats-Bastardas M, Husain RA, Baumann M, Köhler C, Trollmann R, Schwerin-Nagel A, Eisenkölbl A, Schimmel M, Fleger M, Kauffmann B, Wiegand G, Baumgartner M, Rauscher C, Cirak S, Gläser D, Bernert G, Hagenacker T, Goldbach S, Probst-Schendzielorz K, Lochmüller H, Müller-Felber W, Schara-Schmidt U, Walter MC, Kirschner J, Pechmann A, SMARTCARE study group. +41 moreeuropepmc +1 more sourceBiallelic variants in the non-coding RNA gene RNU4-2 cause a recessive neurodevelopmental syndrome with distinct white matter changes
Rius R, Blakes AJ, Chen Y, De Jonghe J, Alvi JR, Amblard F, Austin-Tse C, Baer S, Balasubramanian M, Balton EV, Barcia G, Bernstein JA, Blanc P, Buchzik D, Calame DG, Cogne B, Coutton C, Cunningham CA, Dargie N, Depienne C, Dipple KM, Dieux A, Dixit A, Dreyer L, Du H, El Chehadeh S, Field M, Geiger V, Gibbs RA, Glass I, Grunewald O, Gueguen P, Haack TB, Hadj Abdallah H, Harbuz R, Isidor B, Jacquemont M, Jeanne M, Korenke GC, Kotzaeridou U, Leventer RJ, Lupski JR, Marijon P, McGinnis KE, Mendez R, Messaoud O, Nava C, Nizard M, O’Donnell-Luria A, O’Leary MC, Olivieri S, Parida A, Pehlivan D, Posey JE, Reuter CM, Satre V, Schluth-Bolard C, Smol T, Sultan T, Thauvin C, Thevenon J, Uebergang E, Vincent-Delorme C, Wassmer E, Wheeler MT, Yilmaz Gulec E, Vanderver A, Vossough A, Sanders SJ, Banka S, Findlay GM, MacArthur DG, Simons C, Whiffin N. +73 moreeuropepmc +1 more sourceSome of the next articles are maybe not open access.Related searches:
The possibilities of Mexidol usage in neuropediatrics
Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova, 2023 Mexidol (ethylmethylhydroxypyridine succinate) is a modern neurometabolic medication increasingly being used in neuropediatrics. The results of recent studies confirming the positive effects of Mexidol pharmacotherapy in children with attention deficit hyperactivity disorder (ADHD), perinatal damages of the central nervous system (hypoxic-ischemic ...N.N. Zavadenko, N.Yu. Suvorinova, A.N. Zavadenko +2 moreexaly +3 more sources
